1. Home
  2. ADMA vs FOUR Comparison

ADMA vs FOUR Comparison

Compare ADMA & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$20.16

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Shift4 Payments Inc.

FOUR

Shift4 Payments Inc.

HOLD

Current Price

$69.07

Market Cap

4.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
FOUR
Founded
2004
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ADMA
FOUR
Price
$20.16
$69.07
Analyst Decision
Strong Buy
Buy
Analyst Count
2
21
Target Price
$28.50
$101.29
AVG Volume (30 Days)
3.7M
2.4M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
205.35
14.66
EPS
0.86
2.15
Revenue
$488,559,000.00
$3,878,400,000.00
Revenue This Year
$21.08
$29.56
Revenue Next Year
$25.98
$24.08
P/E Ratio
$23.56
$32.29
Revenue Growth
27.63
23.16
52 Week Low
$13.50
$61.23
52 Week High
$25.67
$127.50

Technical Indicators

Market Signals
Indicator
ADMA
FOUR
Relative Strength Index (RSI) 76.50 44.52
Support Level $18.73 $64.78
Resistance Level $19.48 $75.35
Average True Range (ATR) 0.74 2.62
MACD 0.33 0.54
Stochastic Oscillator 98.00 40.65

Price Performance

Historical Comparison
ADMA
FOUR

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

Share on Social Networks: